Donoghue Forlines’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.58M Buy
+5,837
New +$1.74M 0.44% 95
2024
Q2
Sell
-1,279
Closed -$633K 260
2024
Q1
$633K Buy
1,279
+185
+17% +$94K 0.18% 140
2023
Q4
$576K Sell
1,094
-477
-30% -$254K 0.18% 150
2023
Q3
$792K Buy
1,571
+783
+99% +$385K 0.28% 97
2023
Q2
$379K Buy
+788
New +$385K 0.12% 188
2022
Q4
Sell
-1,319
Closed -$666K 269
2022
Q3
$666K Sell
1,319
-103
-7% -$54.2K 0.24% 70
2022
Q2
$730K Sell
1,422
-185
-12% -$92.9K 0.19% 132
2022
Q1
$820K Buy
+1,607
New +$775K 0.18% 185
2021
Q4
Sell
-2,697
Closed -$1.05M 301
2021
Q3
$1.05M Sell
2,697
-163
-6% -$67.5K 0.2% 118
2021
Q2
$1.15M Sell
2,860
-614
-18% -$245K 0.21% 113
2021
Q1
$1.29M Buy
+3,474
New +$1.2M 0.25% 91
2017
Q4
Sell
-11,550
Closed -$2.26M 147
2017
Q3
$2.26M Buy
+11,550
New +$2.23M 0.24% 75

Other funds holding UNH

Donoghue Forlines's UNH Position: Q1 2026 in Review

Donoghue Forlines opened a new position in UnitedHealth (UNH) in Q1 2026: 5,837 shares worth $1.58M. The stake represents 0.44% of the portfolio and ranks #95 among its holdings. This is a return to the name: Donoghue Forlines previously reported a position in UNH as recently as Q1 2024.

Donoghue Forlines first reported a position in UNH in Q3 2017 and has held it in 12 quarters since. The position peaked at $2.26M in Q3 2017. 3,018 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Donoghue Forlines held 5,837 shares of UnitedHealth worth $1.58M as of Q1 2026.
  • UnitedHealth was a new Donoghue Forlines position in Q1 2026.
  • UnitedHealth made up 0.44% of Donoghue Forlines's portfolio in Q1 2026, its #95 holding.
  • Donoghue Forlines first reported a position in UnitedHealth in Q3 2017 and has held it in 12 quarters since.
  • Donoghue Forlines's UnitedHealth position peaked at $2.26M in Q3 2017.
  • 3,018 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Donoghue Forlines's 13F filing for Q1 2026, filed 13 May 2026.